ANGENOVO AS

Signals

1 flags

• ▼ Driftsunderskudd 2025 Siste driftsresultat er negativt (−108k kr).

ANGENOVO AS is registered as a limited company in Oslo, Oslo with organisation number 922693943. The business is classified under research and experimental development on natural sciences and engineering (NACE 72.100). The company was incorporated in 2019. Registered share capital is NOK 30,000, divided into 10000 shares. The company's stated purpose is: “Importere, eksportere, utvikle og selge kjemiske reagenser og instrumenter for biologisk og medisinsk forskning, og levere dataanalyse og konsulenttjenester.”. The most recent filed accounts, for the 2025 financial year, show NOK 433,000 in revenue and NOK −108,000 in operating profit.

Key figures · 2025

Revenue

NOK 433,000

Operating profit

NOK −108,000

Equity

NOK 166,000

Est. value

NOK 535,000

Financial health · 2024

Liquidity

1.52

Good

Current assets ÷ current liabilities

Profitability

–

Not available

Return on total assets

Solidity

49.3%

Very good

Equity as a share of total capital

Who owns ANGENOVO AS?

PRIMEBIO HOLDING AS

100.0%

ANGENOVO AS

NOK 433,000 rev. · NOK −108,000 profit

ANGENOVO AS has 1 registered shareholder:

• PRIMEBIO HOLDING AS 100.0%

All shareholders and roles →

Frequently asked questions about ANGENOVO AS

Who owns ANGENOVO AS?

PRIMEBIO HOLDING AS is the largest registered owner, with 100.0%.

What is the revenue of ANGENOVO AS?

ANGENOVO AS had revenue of NOK 433,000 in 2025.

Who is the general manager of ANGENOVO AS?

Yanwu Guo is registered as general manager of ANGENOVO AS.

Where is ANGENOVO AS based?

ANGENOVO AS has its business address in Oslo.

Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.